BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16189005)

  • 1. Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein.
    Haffar O; Dubrovsky L; Lowe R; Berro R; Kashanchi F; Godden J; Vanpouille C; Bajorath J; Bukrinsky M
    J Virol; 2005 Oct; 79(20):13028-36. PubMed ID: 16189005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.
    Friedler A; Zakai N; Karni O; Broder YC; Baraz L; Kotler M; Loyter A; Gilon C
    Biochemistry; 1998 Apr; 37(16):5616-22. PubMed ID: 9548947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.
    Haffar OK; Popov S; Dubrovsky L; Agostini I; Tang H; Pushkarsky T; Nadler SG; Bukrinsky M
    J Mol Biol; 2000 Jun; 299(2):359-68. PubMed ID: 10860744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.
    Kootstra NA; Schuitemaker H
    Virology; 1999 Jan; 253(2):170-80. PubMed ID: 9918876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein.
    Zentner I; Sierra LJ; Fraser AK; Maciunas L; Mankowski MK; Vinnik A; Fedichev P; Ptak RG; Martín-García J; Cocklin S
    ChemMedChem; 2013 Mar; 8(3):426-32. PubMed ID: 23361947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
    Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
    Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication.
    Garbitt RA; Bone KR; Parent LJ
    J Virol; 2004 Dec; 78(24):13534-42. PubMed ID: 15564464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitor of HIV-1 nuclear import suppresses HIV-1 replication in human lymphoid tissue ex vivo: a potential addition to current anti-HIV drug repertoire.
    Glushakova S; Dubrovsky L; Grivel J; Haffar O; Bukrinsky M
    Antiviral Res; 2000 Aug; 47(2):89-95. PubMed ID: 10996396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import.
    Mannioui A; Nelson E; Schiffer C; Felix N; Le Rouzic E; Benichou S; Gluckman JC; Canque B
    Virology; 2005 Aug; 339(1):21-30. PubMed ID: 15963546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.
    Zhan P; Liu X; De Clercq E
    Curr Med Chem; 2010; 17(6):495-503. PubMed ID: 20015032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nuclear export activity in HIV-1 matrix protein required for viral replication.
    Dupont S; Sharova N; DéHoratius C; Virbasius CM; Zhu X; Bukrinskaya AG; Stevenson M; Green MR
    Nature; 1999 Dec; 402(6762):681-5. PubMed ID: 10604476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
    Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D; Goldstein SL; Notkins AL; Zhou P
    J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins.
    Rice WG; Baker DC; Schaeffer CA; Graham L; Bu M; Terpening S; Clanton D; Schultz R; Bader JP; Buckheit RW; Field L; Singh PK; Turpin JA
    Antimicrob Agents Chemother; 1997 Feb; 41(2):419-26. PubMed ID: 9021201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.
    Popov S; Rexach M; Zybarth G; Reiling N; Lee MA; Ratner L; Lane CM; Moore MS; Blobel G; Bukrinsky M
    EMBO J; 1998 Feb; 17(4):909-17. PubMed ID: 9463369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
    Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
    Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.
    Fouchier RA; Meyer BE; Simon JH; Fischer U; Malim MH
    EMBO J; 1997 Aug; 16(15):4531-9. PubMed ID: 9303297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of viral assembly in murine cells by HIV-1 matrix.
    Hübner W; Chen BK
    Virology; 2006 Aug; 352(1):27-38. PubMed ID: 16750235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.